|
Q2 FY2027
As of Sep 30, 2026
|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Inventories | |||||||||||||||||||
| Prepayments and other current assets | |||||||||||||||||||
| Investments | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Non current assets | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Non marketable securities | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Other long-term assets | |||||||||||||||||||
| Total Non current assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Current liabilities | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Current portion of long-term borrowings | |||||||||||||||||||
| Short-term borrowings | |||||||||||||||||||
| Due to insurer | |||||||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||||||
| Derivative warrant liabilities | |||||||||||||||||||
| Short-term operating lease liabilities | |||||||||||||||||||
| Other current liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Long-term borrowings | |||||||||||||||||||
| Long-term operating lease liabilities | |||||||||||||||||||
| Other long-term liabilities | |||||||||||||||||||
| Total Non current liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Shareholders’ Equity/(Deficit) | |||||||||||||||||||
| Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of September 30, 2026 and March 31, 2026; 85,295,834 and 79,695,672 shares outstanding as of September 30, 2026 and March 31, 2026, respectively | |||||||||||||||||||
| Total ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of September 30, 2026 and March 31, 2026; 85,295,834 and 79,695,672 shares outstanding as of September 30, 2026 and March 31, 2026, respectively | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive income/(loss) | |||||||||||||||||||
| Other components of equity | |||||||||||||||||||
| Total shareholders’ deficit | |||||||||||||||||||
| Share Application Money | |||||||||||||||||||
| Non-controlling interest | |||||||||||||||||||
| Total deficit | |||||||||||||||||||
| Total liabilities and Total Deficit | |||||||||||||||||||
Loading...